Azienda Ospedaliera Ordine Mauriziano di Torino

Quick facts

Phase 2 pipeline

• Trastuzumab or Lapatinib

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Azienda Ospedaliera Ordine Mauriziano di Torino portfolio CI brief
• Azienda Ospedaliera Ordine Mauriziano di Torino pipeline updates RSS

Related

• Sector hub: All tracked pharma companies